Osteoporosis: diagnostic testing, interpretation, and correlations with oral health--implications for dentistry

Dent Clin North Am. 2005 Apr;49(2):463-84. doi: 10.1016/j.cden.2004.10.005.


Osteoporosis affects over 10 million Americans, including over 2 million men. Dentistry is in a position to work alongside medicine to assist the population in preventing and coping with this condition. This article provides an overview of osteoporosis, including its causes, assessment, prevention, and treatment. Various pharmacologic agents are reviewed, including bisphosphonates, selective estrogen receptor modulators, calcitonin, anabolic agents, and fluoride. The article also discusses the dentist's role in prevention, risk assessment, diagnosis, nutrition counseling, and evaluating the impact of the disease and its treatment on dental management and treatment planning. As dental implants become more in demand, the prognosis for and potential complications of implant therapy in patients with osteoporosis are a matter of intense interest.

Publication types

  • Review

MeSH terms

  • Aged
  • Anabolic Agents / therapeutic use
  • Calcitonin / therapeutic use
  • Dental Implants
  • Diphosphonates / therapeutic use
  • Female
  • Fluorides / therapeutic use
  • Humans
  • Male
  • Oral Health*
  • Osteoporosis / diagnostic imaging*
  • Osteoporosis / prevention & control
  • Radiography
  • Selective Estrogen Receptor Modulators / therapeutic use


  • Anabolic Agents
  • Dental Implants
  • Diphosphonates
  • Selective Estrogen Receptor Modulators
  • Calcitonin
  • Fluorides